NWF Advisory Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$256K Buy
1,834
+1
+0.1% +$140 0.03% 321
2025
Q4
$225K Buy
+1,833
New +$223K 0.02% 338
2025
Q3
Sell
-2,162
Closed -$240K 432
2025
Q2
$240K Buy
2,162
+299
+16% +$31.8K 0.03% 337
2025
Q1
$209K Sell
1,863
-372
-17% -$38.4K 0.03% 318
2024
Q4
$206K Buy
+2,235
New +$201K 0.03% 253

Other funds holding GILD

NWF Advisory Services's GILD Position: Q1 2026 in Review

NWF Advisory Services increased its Gilead Sciences (GILD) stake by 0.05% in Q1 2026, buying an estimated $140 and bringing the position to 1,834 shares worth $256K. The position accounts for 0.03% of the portfolio, ranked #321.

NWF Advisory Services first reported a position in GILD in Q4 2024 and has held it in 5 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • NWF Advisory Services held 1,834 shares of Gilead Sciences worth $256K as of Q1 2026.
  • NWF Advisory Services bought 1 Gilead Sciences share in Q1 2026, an estimated $140.
  • Gilead Sciences made up 0.03% of NWF Advisory Services's portfolio in Q1 2026, its #321 holding.
  • NWF Advisory Services first reported a position in Gilead Sciences in Q4 2024 and has held it in 5 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on NWF Advisory Services's 13F filing for Q1 2026, filed 4 May 2026.